What other costs are associated with carrying out this global plan for treating SCD and related diseases?




The next cost hurdle is for further experiments to show that our cure is safe in animals and, in the same experiments, show that our ways of delivering the cure (as an injection or as a pill) will work in animals. This is also an expensive step on the way to clinical application. But it is an essential step before clinical trials in humans can be started.